Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call Transcript

2025-03-25 10:05:16 ET

Atossa Therapeutics, Inc. (ATOS)

Q4 2024 Earnings Conference Call

March 25, 2025 08:30 AM ET

Company Participants

Michael Parks - VP of Investor and Public Relations

Steven Quay - President and CEO

Heather Rees - CFO

Conference Call Participants

Emily Bodnar - H.C. Wainwright

Edward Woo - Ascendiant Capital

Presentation

Operator

Good morning, everyone, and welcome to the Atossa Therapeutics Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is Joelle, and I will be your conference operator today. All participants will be in a listen-only mode. [Operator Instructions] A replay of this call will be available on the Investor Relations section of the Atossa Therapeutics website after its conclusion. I will now turn the call over to Michael Parks, Vice President of Investor Relations at Atossa Therapeutics. Michael, please proceed.

Michael Parks

Thank you, Joelle. Good morning, everyone, and welcome to Atossa Therapeutics conference call to discuss our year-end 2024 financial results and business update. The press release on these financial results was issued this morning and can be found in our Investors section of the corporate website at atossatherapeutics.com. On this morning's call, a team will provide a business overview of our progress in 2024 and recent events....

Read the full article on Seeking Alpha

For further details see: